Per Olav Vandvik

2004–2025 年に発表

148
論文数
24,376
被引用数
83
h 指数
134
i10 指数

被引用数

Per Olav Vandvik の年別被引用数1992 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 6 件2006 年: 被引用 7 件2007 年: 被引用 6 件2008 年: 被引用 10 件2009 年: 被引用 14 件2010 年: 被引用 17 件2011 年: 被引用 11 件2012 年: 被引用 100 件2013 年: 被引用 100 件2014 年: 被引用 125 件2015 年: 被引用 119 件2016 年: 被引用 187 件2017 年: 被引用 216 件2018 年: 被引用 193 件2019 年: 被引用 689 件2020 年: 被引用 946 件2021 年: 被引用 1,131 件2022 年: 被引用 936 件2023 年: 被引用 644 件2024 年: 被引用 1,022 件2025 年: 被引用 564 件2026 年: 被引用 23 件1993〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,372 件、この内訳の 16.1%カナダ: 引用元論文 1,278 件、この内訳の 8.7%イギリス: 引用元論文 1,208 件、この内訳の 8.2%中国: 引用元論文 865 件、この内訳の 5.9%イタリア: 引用元論文 649 件、この内訳の 4.4%オーストラリア: 引用元論文 637 件、この内訳の 4.3%ドイツ: 引用元論文 596 件、この内訳の 4.1%オランダ: 引用元論文 564 件、この内訳の 3.8%スペイン: 引用元論文 450 件、この内訳の 3.1%スイス: 引用元論文 423 件、この内訳の 2.9%フランス: 引用元論文 385 件、この内訳の 2.6%ノルウェー: 引用元論文 293 件、この内訳の 2%
0%16.1%その他 33.9%

分野

  • Medicine76.6%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Health Professions4.9%
  • Decision Sciences2.2%
  • Agricultural and Biological Sciences1.5%
  • Engineering1.2%
  • その他8.5%

トピック

  • COVID-19 Clinical Research Studies3.2%
  • Diabetes Treatment and Management2.6%
  • Venous Thromboembolism Diagnosis and Management1.9%
  • SARS-CoV-2 and COVID-19 Research1.5%
  • Meta-analysis and systematic reviews1.5%
  • Long-Term Effects of COVID-191.5%
  • その他87.8%

共著者

全論文

検索で開く
  1. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xiangyang Chen, Xu Zhou, Jiali Liu, Andrea Flores Rodríguez, Alejandro Díaz González-Colmenero, Yang Wang, Ling Li, Surya Sutanto, Ricardo César Solís, Fernando Díaz González-Colmenero, René Rodríguez‐Gutiérrez, Michael Walsh, Gordon Guyatt, Giovanni FM Strippoli - BMJ 2021 被引用: 672

  2. Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xiangyang Chen, Xiafei Lyu, Xingxing An, Yaolong Chen, Qiukui Hao, Eberhard Standl, Reed Siemieniuk, Thomas Agoritsas, Haoming Tian, Sheyu Li - BMJ 2023 被引用: 276

  3. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

    著者: , , , , , , , , , , , , , , , , - BMJ 2015 被引用: 865

  4. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines

    著者: , , , , , , , , , , , , - BMJ 2016 被引用: 813

  5. Real-Time Computer-Aided Detection of Colorectal Neoplasia During Colonoscopy

    著者: , , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2023 被引用: 189

  6. Retracted: Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 被引用: 274

  7. Opioids for Chronic Noncancer Pain

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bradley C. Johnston, Regina Kunz, Xin Sun, Norman Buckley, Daniel I. Sessler, Gordon Guyatt - JAMA 2018 被引用: 711

  8. GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Epidemiology 2020 被引用: 402

  9. A living WHO guideline on drugs for covid-19 (2020-2023)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Muhammad Mohsin Haider, Matthias Götte, Nerina Harley, Madiha Hashmi, David S.C. Hui, Mohamed Ismail, Fyezah Jehan, Sushil Kumar Kabra, Seema Kanda, Yae‐Jean Kim, Niranjan Kissoo, Sanjeev Krishna, Krutika Kuppalli, Arthur Kwizera, Marta Lado Castro-Rial, Thiago Lisboa, Rakesh Lodha, Imelda Mahaka, Hela Manai, Marc Mendelson, Giovanni Battista Migliori, G Miño, Emmanuel Nsutebu, Jessica Peter, Jacobus Preller, N. Pshenichnaya, Nida Qadir, Shalini Sri Ranganathan, Pryanka Relan, Jamie Rylance, Saniya Sabzwari, Rohit Sarin, Manu Shankar‐Hari, Michael Sharland, Yinzhong Shen, João Paulo Souza, Ronald Swanstrom, Tshokey Tshokey, Sebastián Ugarte, Timothy M. Uyeki, Evangelina Vázquez Curiel, Sridhar Venkatapuram, Dubula Vuyiseka, Ananda Wijewickrama, Lien Tran, Dena Zeraatkar, Jessica J Bartoszko, Long Ge, Romina Brignardello‐Petersen, Andrew Owen, Gordon Guyatt, Janet Dı́az, Letícia Kawano-Dourado, Michael Jacobs, Per Olav Vandvik - BMJ 2020 被引用: 1,089

  10. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2024 被引用: 132

  11. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children

    著者: , , , , , , , - Cochrane Database of Systematic Reviews 2013 被引用: 741

  12. VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy

    著者: , , , , , - CHEST Journal 2012 被引用: 1,509

  13. Drug treatments for covid-19: living systematic review and network meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Loeb, Anna Miroshnychenko, Maura Marcucci, Shelley McLeod, Sharhzad Motaghi, Srinivas Murthy, Reem A. Mustafa, Héctor Pardo‐Hernández, Gabriel Rada, Yamna Rizwan, Pakeezah Saadat, Charlotte Switzer, Lehana Thabane, George Tomlinson, Per Olav Vandvik, Robin W.M. Vernooij, Andrés Viteri-García, Ying Wang, Liang Yao, Yunli Zhao, Gordon Guyatt, Romina Brignardello‐Petersen - BMJ 2020 被引用: 912

  14. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis

    著者: , , , , , , , , , , , - BMJ 2022 被引用: 140

  15. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline

    著者: , , , , , , , , , , , , , , , , , , , - BMJ 2023 被引用: 127

  16. Guideline for opioid therapy and chronic noncancer pain

    著者: , , , , , , , , , , , , , , , , , , , - Canadian Medical Association Journal 2017 被引用: 729

  17. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

    著者: , , , , , , , , , , , , , , , , , , - BMJ 2018 被引用: 185

  18. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - BMJ 2021 被引用: 120

  19. Evidence-Based Management of Anticoagulant Therapy

    著者: , , , , , , , , , - CHEST Journal 2012 被引用: 1,260

  20. Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis

    著者: , , , , , - BMJ Open 2019 被引用: 139

  21. Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis

    著者: , , , , , , , , , , , , , , , , - Critical Care Medicine 2018 被引用: 258

  22. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

    著者: , , , , , , , , , , , - BMJ 2014 被引用: 248

  23. Decision makers need constantly updated evidence synthesis

    著者: , , , , , , , , , - Nature 2021 被引用: 163

  24. Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies

    著者: , , , , , , , , , , , , , , , - BMJ Medicine 2022 被引用: 38